Antonella Cianferoni

faculty photo
Associate Professor of Pediatrics (Allergy/Immunology) at the Children's Hospital of Philadelphia
Department: Pediatrics

Contact information
Children's Hospital of Philadelphia
1216H ARC Allergy Immunology
34th and Center Boulevard
Philadelphia, PA 19104-4399
Office: 2674267831
Fax: 2674260363
Lab: 2672941952
Education:
MD (Medicine)
University of Florence, Italy, 1996.
PhD (Pediatric Immunology)
University of Florence, Italy, 2004.
Post-Graduate Training
Resident, Pediatrics, A. Meyer Hospital, University of Florence, Italy, 1996-1997.
Research Fellow, Allergy and Immunology, Johns Hopkins University, Baltimore, MD, 1997-1999.
Clinical Fellow, Allergy and Immunology, Boston Children's Hospital and Brigham and Women's Hospital, Boston, MA, 2002-2005.
Resident, Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, 2005-2007.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

I am a pediatric allergist and immunologist with an interest in human food allergy immunopathogenesis. While my interest in allergic disease has been long-standing and continuous, the path to my current position and research endeavors has involved numerous institutions, as well as shifts between scientific and clinical training opportunities. I began my research career as a medical student and pediatric resident in Italy. There, I clinically characterized several classical allergic diseases including anaphylaxis and atopic dermatitis. I completed a Ph.D. in Immunology and pursued various research training opportunities in the United States, including a research fellowship at Johns Hopkins and a fellowship in Allergy and Immunology at Children’s Hospital Boston. Today I am an Assistant Professor of Pediatrics at The Children’s Hospital of Philadelphia (CHOP) where I study the role of iNKT cells in food allergy pathogenesis.
The above-mentioned training opportunities afforded me a variety of research experiences as well as exposure to a broad range of research styles, techniques and experimental paradigms; looked at purely from a publication productivity standpoint, however, the short-term nature of many of these experiences (on average 2 years in duration) was somewhat limiting. As I initiated each of the research projects I pursued, each, on average, resulted in only one first author publication. For example, at Hopkins, I studied the effect of aspirin on IL-4 transcription using a human cellular model (10), whereas at Boston Children’s I worked on IL-2 transcription using a mouse model of Wiskott-Aldrich Disease (21). These research experiences were separated by 3 years of clinical activity in Italy where I completed my Residency in Pediatrics. Following my research in Boston, I again shifted to clinical training, completing 3 years of clinical training in Pediatrics and Allergy and Immunology. Completion of this clinical work was required for U.S. Board Certification. Beginning with my appointment as Assistant Professor of Pediatrics at CHOP, I have been able to resume my research activities. Rather than continue research started at either Hopkins or Boston Children’s, however, I have chosen to focus my research efforts on a novel line of inquiry in food allergy. Today, my laboratory strives to understand how food-derived lipids contribute to food allergy sensitization, and in particular, how these lipids influence chronic atopic states like eosinophilic esophagitis (EoE) by activating iNKTs. To this end, I have developed state-of-the-art techniques to investigate, at a molecular level, this rare cell population in humans. This research led me to obtain NIH funding (K12 first for 2 years and more recently a K08 grant) a senior publication on JACI, coauthoira Nature a nature genetics paper and data for 4 more publications that are being submitted.

Our paper , for the first time, demonstrated that milk-derived lipids activate iNKTs via the TCR to produce Th2 cytokines, and that qualitative and quantitative differences in iNKTs exist between children with food allergies and their healthy counterparts. Our current research focuses on defining the role of iNKTs in Food allergy using the Eosinophilic Esophagitis model boith in human and in animals, as iNKTs appear to favor the development of other atopic diseases such as asthma and contact dermatitis, I anticipate that these studies will provide generalizable insights into how iNKT cells can be modulated to enhance treatment of patients with food allergies.

The dynamic and rich research environments at CHOP and the University of Pennsylvania have provided me with a wealth of mentors and collaborators, including leaders in the fields of iNKT, NK cell and T cell biology (Dr. Koretsky, Professor, Pathology and Laboratory Medicine University of Pennsylvania School of Medicine, Investigator and Director, Signal Transduction Program; Dr. Nichols, Associate Professor of Pediatrics, University of Pennsylvania, Oncology Division; and Dr. Orange Associate Professor of Pediatrics University of Pennsylvania, Allergy and Immunology Division). Additionally, I have capitalized on my prior research experiences and training to involve mentors from outside institutions (Dr. Brenner, Theodore B. Bayles Professor, Department of Medicine, Harvard Medical School Chief, Rheumatology, Immunology and Allergy, Brigham And Women's Hospital and Dr Boyson, Associate Professor, Associate Professor of Surgery and Director of Surgical Research, University of Vermont).

Description of Itmat Expertise

Dr. Cianferoni is conducting translational research in allergies with a specific interest in food allergies, targeting the pathogenesis of food allergies using human blood sample from patients, normal donors and animal models.

Selected Publications

Pitsios C, Rossi CM, Terreehorst I, Heffler E, Votto M, Konstantinou GN, Alvarez-Perea A, Bakirtas A, Apostolidou E, Antolin-Amerigo D, Nikolopoulos GK, Pfaar O, Cianferoni A.: Eosinophilic esophagitis as a side-effect of allergen immunotherapy: protocol for a systematic review and meta-analysis Eur Ann Allergy Clin Immunol 56(1): 4-8, Jan 2024.

Nguyen K, Lewis MO, Hanna E, Alfaro MKC, Corrigan K, Buonanno J, Datta R, Brown-Whitehorn T, Spergel JM, Cianferoni A.: Safety of Multifood Oral Immunotherapy in Children Aged 1 to 18 Years at an Academic Pediatric Clinic. J Allergy Clin Immunol Pract 11(6): 1907-1913, Jun 2023.

Kliewer KL, Gonsalves N, Dellon ES, Katzka DA, Abonia JP, Aceves SS, Arva NC, Besse JA, Bonis PA, Caldwell JM, Capocelli KE, Chehade M, Cianferoni A, Collins MH, Falk GW, Gupta SK, Hirano I, Krischer JP, Leung J, Martin LJ, Menard-Katcher P, Mukkada VA, Peterson KA, Shoda T, Rudman Spergel AK, Spergel JM, Yang GY, Zhang X, Furuta GT, Rothenberg ME.: One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial. Lancet Gastroenterol Hepatol 8(5): 408-421, May 2023.

Schultz F, Warren CM, Chehade M, Cianferoni A, Gerdts J, Groetch M, Gupta RS, Strobel MJ, Upton JEM, Venter C, Waserman S, Nowak-Wegrzyn A.: When Supplemental Formula Is Essential: Overcoming Barriers to Hypoallergenic Formula Access for Patients With Food Allergies. J Allergy Clin Immunol Pract 11(9): 2686-2692, May 2023.

kkerdaas JH, Cianferoni A, Islamovic E, Kough J, Ladics GS, McClain S, Poulsen LK, Silvanovich A, Pereira Mouriès L, van Ree R.: Impact of Food Matrices on Digestibility of Allergens and Poorly Allergenic Homologs. Front Allergy 31(3): e909410, May 2023.

Arasi S, Nurmatov U, Dunn-Galvin A, Roberts G, Turner PJ, Shinder SB, Gupta R, Eigenmann P, Nowak-Wegrzyn A, Ansotegui IJ, Rivas MF, Petrou S, Tanno LK, Vazquez-Ortiz M, Vickery B, Wong G, Alvaro-Lozano M, Asaria M, Begin P, Bozzola M, Boyle R, Brough H, Cardona V, Chinthrajah RS, Cianferoni A, Deschildre A, Fleischer D, Gazzani F, Gerdts J, Giannetti M, Greenhawt M, Guzmán MA, Hossny E, Kauppi P, Jones C, Lucidi F, Monge Ortega OP, Munblit D, Muraro A, Pajno G, Podestà M, Rodriguez Del Rio P, Said M, Santos A, Shaker M, Szajewska H, Venter C, Warren C, Winders T, Ebisawa M, Fiocchi A.: WAO consensus on Definition of Food Allergy Severity (DEFASE). World Allergy Organ J 16(1): 100753, Mar 2023.

Wise SK, Damask C, Roland LT, Ebert C, Levy JM, Lin S, Luong A, Rodriguez K, Sedaghat AR, Toskala E, Villwock J, Abdullah B, Akdis C, Alt JA, Ansotegui IJ, Azar A, Baroody F, Benninger MS, Bernstein J, Brook C, Campbell R, Casale T, Chaaban M, Chew FT, Chambliss J, Cianferoni A, Custovic A, Davis EM, DelGaudio JM, Ellis AK, Flanagan C, Fokkens WJ, Franzese C, Greenhawt M, Gill A, Halderman A, Hohlfeld JM, Incorvaia C, Joe SA, Joshi S, Kuruvilla ME, Kim J, Klein AM, Krouse HJ, Kuan EC, Lang D, Larenas-Linnemann D, Laury AM, Lechner M, Lee SE, Lee VS, Loftus P, Marcus S, Marzouk H, Mattos J, McCoul E, Melen E, Mims JW, Mullol J, Nayak JV, Oppenheimer J, Orlandi RR, Phillips K, Platt M, Ramanathan M Jr, Raymond M, Rhee CS, Reitsma S, Ryan M, Sastre J, Schlosser RJ, Schuman TA, Shaker MS, Sheikh A, Smith KA, Soyka MB, Takashima M, Tang M, Tantilipikorn P, Taw MB, Tversky J, Tyler MA, Veling MC, Wallace D, Wang Y, White A, Zhang L.: International consensus statement on allergy and rhinology: Allergic rhinitis - 2023. Int Forum Allergy Rhinol 13(14): 293-859, Jan 2023.

Muir AB, Brown-Whitehorn T, Cianferoni A.: It takes a village to manage eosinophilic esophagitis. Ann Allergy Asthma Immunol 130(1): 13-14, Jan 2023.

Muraro A, de Silva D, Halken S, Worm M, Khaleva E, Arasi S, Dunn-Galvin A, Nwaru BI, De Jong NW, Rodríguez Del Río P, Turner PJ, Smith P, Begin P, Angier E, Arshad H, Ballmer-Weber B, Beyer K, Bindslev-Jensen C, Cianferoni A, Demoulin C, Deschildre A, Ebisawa M, Fernandez-Rivas MM, Fiocchi A, Flokstra-de Blok B, Gerdts J, Gradman J, Grimshaw K, Jones C, Lau S, Loh R, Alvaro Lozano M, Makela M, Marchisotto MJ, Meyer R, Mills C, Nilsson C, Nowak-Wegrzyn A, Nurmatov U, Pajno G, Podestà M, Poulsen LK, Sampson HA, Sanchez A, Schnadt S, Szajewska H, Van Ree R, Venter C, Vlieg-Boerstra B, Warner A, Wong G, Wood R, Zuberbier T, Roberts G; GA2LEN Food Allergy Guideline Group; GALEN Food Allergy Guideline Group.: Managing food allergy: GA(2)LEN guideline 2022. World Allergy Organ J 15(1): 100687, Sep 2022.

Pitsios C, Vassilopoulou E, Pantavou K, Terreehorst I, Nowak-Wegzryn A, Cianferoni A, Tsigkrelis GP, Papachristodoulou M, Bonovas S, Nikolopoulos GK.: Allergy-Test-Based Elimination Diets for the Treatment of Eosinophilic Esophagitis: A Systematic Review of Their Efficacy. J Clin Med 11(1): 5631, Sep 2022.

back to top
Last updated: 04/22/2024
The Trustees of the University of Pennsylvania